Fırat Izgi Attorney Partnership updates

Pharmaceutical market access in Turkey – a regulatory roadmap
Fırat Izgi Attorney Partnership
  • Healthcare & Life Sciences
  • Turkey
  • February 28 2018

The government aims to make Turkey one of the world's top 10 economies in the field of health services by 2023. As a result, Turkey's pharma industry is expected to reach $23 billion turnover by 2023 and imported products will continue to account for approximately half of the market share. The import of pharmaceuticals is expected to maintain its significant market share in the coming years.

Current search